Cisplatin, Gemcitabine and Bevacizumab in Combination for Metastatic Transitional Cell Cancer
Clinical trial NCT00234494 · COMPLETED
Trial details
- NCT number
- NCT00234494
- Sponsor
- Christopher Sweeney, MBBS
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2005-11-01
- Primary completion
- 2008-12-01
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.